A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon

PURPOSE: When combined with chemotherapy, bevacizumab improves progression-free survival (PFS) in metastatic colorectal cancer (mCRC). This observational trial was designed to assess the safety and efficacy of bevacizumab plus first-line chemotherapy in a real-world setting in Lebanon. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Temraz, Sally, Nasr, Fadi, Kattan, Joseph, Abigerges, Dany, Moukadem, Walid, Farhat, Fadi, Maatouk, Layal, Chahine, Georges, Shamseddine, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881008/
https://www.ncbi.nlm.nih.gov/pubmed/35221671
http://dx.doi.org/10.2147/BTT.S340525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881008/
https://www.ncbi.nlm.nih.gov/pubmed/35221671
http://dx.doi.org/10.2147/BTT.S340525

Ejemplares similares